PRQR insider buying
Every open-market purchase of ProQR Therapeutics N.V. (PRQR) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$1.34M
Insiders buying (12m)2
Purchases on record5
Last purchase filedAug 3, 2026
In the last 12 months, 2 insiders of ProQR Therapeutics N.V. bought $1.34M of PRQR stock on the open market in 5 reported purchases. The most recent was filed on Aug 3, 2026: de Boer Daniel Anton (Chief Executive Officer, Director) bought 200,000 shares at $1.77, worth $354K.
Get the next PRQR insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll PRQR insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Aug 3 | de Boer Daniel AntonChief Executive Officer, Director | $354K | 200,000 | $1.77 | +67% | Jul 31 | SEC |
| Jul 21 | Filius BartDirector | $258K | 150,000 | $1.72 | +100% | Jul 17 | SEC |
| Jul 13 | de Boer Daniel AntonChief Executive Officer, Director | $261K | 150,000 | $1.74 | +100% | Jul 9 | SEC |
| Jul 8 | de Boer Daniel AntonChief Executive Officer, Director | $238.50K | 150,000 | $1.59 | new | Jul 7 | SEC |
| Jun 30 | Filius BartDirector | $231K | 150,000 | $1.54 | new | Jun 26 | SEC |